The New Frontier of Autism Research & Factors We Need to Consider | Dr. Karen Parker & Jim Kwik

Dr. Karen Parker, Stanford University, focuses on autism’s biological basis. Her research, which measures vasopressin and oxytocin levels in cerebrospinal fluid, found males with autism have significantly lower vasopressin levels. Intranasal vasopressin improved social abilities in autistic children, suggesting potential treatments. Autism, behaviourally diagnosed using DSM-5 criteria, often faces delays in diagnosis due to specialist shortages. Dr. Parker advocates for lab-based diagnostic tests and emphasizes the need for interdisciplinary collaboration and innovative research to identify and treat autism effectively.

Share the Post:

Related Posts

Join Our Newsletter